Among those identified, 2.4 lakh patients have been notified from public health institutions, while 1.1 lakh were identified through private healthcare facilities
Collaborates with VisionSpring to conduct eye check-up camps for underprivileged children
Revenue from operations also dropped 8.3 per cent at Rs. 133.5 crore in Q3 FY25
Observations are largely around improvement of procedures and practices
This strategic partnership will also enable KIMS to exercise call option (not an obligation) to acquire majority stake in UAIMS Hospital in the coming years
Vaccine helps protect against five common disease-causing serogroups of Neisseria meningitidis (A, B, C, W and Y)
Revenue up 11% to Rs 5,768 crore as compared to Rs 5,197 crore
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries
Next-generation lens features purely refractive design, delivering uninterrupted high-quality vision with high best-in-category contrast & low-light performance
Approval is based on positive data from the Phase 3 ECHELON-3 trial
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
